ArticleMethods in molecular biology (Clifton, N.J.)2025
Application of Isotope Dilution Gas Chromatography-Mass Spectrometry Using Selected Ion-Monitoring to Evaluate Nonenzymatic Protein Damage in Cerebrospinal Fluid.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mass spectrometry (MS)-based approach for the detection and quantification of nonenzymatic posttranslational modifications (PTMs) is a powerful technology to measure the dynamics of proteome damage with high throughput and deep coverage. Here, we describe a gas chromatography-mass spectrometry with a selected ion-monitoring mode (SIM-GC/MS) method for protein damage profiling of biological and clinical samples. This approach can be carried out on materials ranging from isolated proteins to tissue/biofluid samples. In particular, the SIM-GC/MS method is applied to detect and quantify diverse protein damage markers in the human cerebrospinal fluid (CSF) proteome. The protocol includes protein extraction, digestion, derivatization, PTMs detection and quantification by GC/MS, followed by computational data processing. Different protein damage markers of oxidation, glycoxidation, lipoxidation and succination can be confidently detected and quantified simultaneously. This protocol provides a general protein nonenzymatic modification measurement tool, enabling the dissection of protein and proteome modifications in a particular biofluid, the CSF.
Indexed as
Identifiers
40167914What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.